Clinical Trials

Any further development efforts for either of our product candidates is dependent on our ability to raise additional capital.

Enclomiphene

Current recruiting locations:


Arkansas
Little Rock

New Jersey
Garden City
New York
Albany

Utah
Riverton
Virginia
Norfolk

Ongoing Studies

Enclomiphene - Diet and Exercise Study (ZA-205) (Currently Recruiting)

Purpose: To compare the effects of treatment with enclomiphene to placebo, upon body composition and metabolic parameters in hypogonadal men undergoing a 6-month diet and 15 month exercise program.

If you have questions about enclomiphene, please call Repros at 800-895-6554 ext 3403 or email studyinfo@reprosrx.com.



Proellex®

If you are interested in participating, and want to know if you may qualify, please call 800-895-6554 ext 3401.


Current recruiting locations:


Arizona
Tucson

Arkansas
Little Rock

Florida
Ft. Lauderdale
Jacksonville
Louisiana
New Orleans

South Carolina
Summerville

Texas
Houston
Utah
Salt Lake City

Virginia
Richmond

Ongoing Studies

Proellex® - Treatment of Pre-Menopausal Women with Confirmed, Symptomatic Endometriosis (ZPE-202) (Currently Enrolling)

Purpose: To determine the safety and efficacy of two doses of Proellex in premenopausal women with pelvic pain in endometriosis confirmed within the last seven years and using prescription analgesics for symptomatic pain.

Proellex® - Treatment of Pre-Menopausal Women with Confirmed, Symptomatic Uterine Fibroids (ZPU-203) (Active)

Purpose: To determine the safety and efficacy of two oral doses of Proellex in premenopausal women with symptomatic uterine fibroids confirmed by MRI.

Proellex® - Treatment of Pre-Menopausal Women with Confirmed, Symptomatic Uterine Fibroids (ZPV-201) (Active)

Purpose: To determine the safety and efficacy of two vaginal doses of Proellex in premenopausal women with symptomatic uterine fibroids confirmed by MRI.

2408 Timberloch Place, B-7
The Woodlands, Texas 77380
281-719-3400
281-719-3446 fax